How High Will Eli Lilly Stock Go By 2030?
The weight loss drugs market is heating up quickly and…
Sell
26
HSII Quote, Financials, Valuation and Earnings
Last price:
$37.99
Seasonality move
:
-4.47%
Day range:
$36.87 - $38.69
52-week range:
$29.03 - $49.02
Dividend yield:
1.61%
P/E ratio:
92.95x
P/S ratio:
0.70x
P/B ratio:
1.69x
Volume:
134.5K
Avg. volume:
158.8K
1-year change:
21.9%
Market cap:
$766.8M
Revenue:
$1.1B
EPS (TTM):
$0.40
Analysts' Opinion
-
Consensus RatingHeidrick & Struggles International has received a consensus rating of Hold. The company's average rating is a Hold based on 0 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $50.67, Heidrick & Struggles International has an estimated upside of 36.27% from its current price of $37.18.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $44.00 representing 100% downside risk from its current price of $37.18.
Fair Value
-
According to the consensus of 1 analyst, Heidrick & Struggles International has 36.27% upside to fair value with a price target of $50.67 per share.
HSII vs. S&P 500
-
Over the past 5 trading days, Heidrick & Struggles International has underperformed the S&P 500 by -7.61% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Heidrick & Struggles International does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Heidrick & Struggles International has grown year-over-year revenues for 6 quarters straight. In the most recent quarter Heidrick & Struggles International reported revenues of $280.9M.
Earnings Growth
-
Heidrick & Struggles International earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Heidrick & Struggles International reported earnings per share of -$0.73.
Enterprise value:
203.3M
EV / Invested capital:
--
Price / LTM sales:
0.70x
EV / EBIT:
2.75x
EV / Revenue:
0.18x
PEG ratio (5yr expected):
--
EV / Free cash flow:
1.64x
Price / Operating cash flow:
6.26x
Enterprise value / EBITDA:
2.19x
Gross Profit (TTM):
$281.1M
Return On Assets:
0.8%
Net Income Margin (TTM):
0.78%
Return On Equity:
1.88%
Return On Invested Capital:
1.88%
Operating Margin:
6.98%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $1.1B | $1B | $1.1B | $257.4M | $280.9M | |
| Gross Profit | $275.5M | $276.1M | $281.1M | $76.1M | $69.8M | |
| Operating Income | $112.3M | $82.6M | $73.9M | $21.9M | $19.6M | |
| EBITDA | $122.9M | $101.1M | $92.8M | $26.9M | $24.8M | |
| Diluted EPS | $3.89 | $2.65 | $0.40 | $0.72 | -$0.73 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $472.7M | $745.4M | $823.8M | $693.2M | $773M | |
| Total Assets | $787.8M | $1.1B | $1.2B | $1.1B | $1.2B | |
| Current Liabilities | $318.2M | $534.7M | $588.5M | $438.7M | $483M | |
| Total Liabilities | $520.2M | $770.8M | $765M | $679.3M | $741.4M | |
| Total Equity | $267.6M | $336M | $410.6M | $462.3M | $452.8M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $119.3M | -$26.8M | $150.4M | $153.8M | $190.2M | |
| Cash From Investing | -$279.6M | $133.6M | -$14.6M | -$33.1M | -$18.4M | |
| Cash From Financing | -$15.7M | -$53.5M | -$16.7M | -$1.1M | -$3.3M | |
| Free Cash Flow | $108.2M | -$40.2M | $124.1M | $150M | $173.5M | |
HSII
Sector
Market Cap
$766.8M
$574.7M
Price % of 52-Week High
75.85%
69.72%
Dividend Yield
1.61%
0%
Shareholder Yield
--
2.29%
1-Year Price Total Return
21.9%
-9.87%
Beta (5-Year)
0.866
0.764
Dividend yield:
1.61%
Annualized payout:
$0.60
Payout ratio:
148.06%
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$39.71
200-day SMA
Sell
Level
$40.88
Bollinger Bands (100)
Sell
Level
41.81 - 46.29
Chaikin Money Flow
Buy
Level
8.7M
20-day SMA
Sell
Level
$41.39
Relative Strength Index (RSI14)
Sell
Level
32.79
ADX Line
Sell
Level
19.75
Williams %R
Buy
Level
-95.4612
50-day SMA
Sell
Level
$42.66
MACD (12, 26)
Sell
Level
-1.32
25-day Aroon Oscillator
Sell
Level
-64
On Balance Volume
Neutral
Level
7.6M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.4032)
Sell
CA Score
(Annual)
Level (-0.3014)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (8)
Sell
Ohlson Score
Level (3.6066)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (4)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Heidrick & Struggles International Inc is a leadership advisory firm providing executive search and consulting services to businesses and business leaders world wide. The company's operating segments include the executive search business which operates in the Americas; Europe; Asia Pacific and On-Demand Talent and Heidrick Consulting. It generates maximum revenue from the Americas.
Stock Forecast FAQ
In the current month, HSII has received 0 Buy ratings 1 Hold ratings, and 0 Sell ratings. The HSII average analyst price target in the past 3 months is $50.67.
-
Where Will Heidrick & Struggles International Stock Be In 1 Year?
According to analysts, the consensus estimate is that Heidrick & Struggles International share price will rise to $50.67 per share over the next 12 months.
-
What Do Analysts Say About Heidrick & Struggles International?
Analysts are divided on their view about Heidrick & Struggles International share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Heidrick & Struggles International is a Sell and believe this share price will drop from its current level to $44.00.
-
What Is Heidrick & Struggles International's Price Target?
The price target for Heidrick & Struggles International over the next 1-year time period is forecast to be $50.67 according to 1 Wall Street analyst, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is HSII A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Heidrick & Struggles International is a Hold. 1 of 1 analysts rates the stock a Hold at this time.
-
How Can I Buy Shares Of HSII?
You can purchase shares of Heidrick & Struggles International via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Heidrick & Struggles International shares.
-
What Is The Heidrick & Struggles International Share Price Today?
Heidrick & Struggles International was last trading at $37.99 per share. This represents the most recent stock quote for Heidrick & Struggles International. Yesterday, Heidrick & Struggles International closed at $37.18 per share.
-
How To Buy Heidrick & Struggles International Stock Online?
In order to purchase Heidrick & Struggles International stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is TSMC the Best Semiconductor Stock to Buy Now?
The new administration has launched a slew of tariffs, paused…
Rocket Lab Vs Intuitive Machines Stock
The commercialization of outer space is now in full swing,…
Stock Ideas
Sell
48
Is AAPL Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 32x
Sell
43
Is MSFT Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 30x
Sell
40
Is NVDA Stock a Buy?
Market Cap: $2.4T
P/E Ratio: 33x
Alerts
Buy
58
AGX alert for Apr 22
Argan [AGX] is up 3.08% over the past day.
Sell
44
INOD alert for Apr 22
Innodata [INOD] is up 5.26% over the past day.
Sell
44
UHS alert for Apr 22
Universal Health Services [UHS] is up 2.73% over the past day.
